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DOI 10.1186/s12940-015-0040-9RESEARCH Open AccessPerfluoroalkyl acids and time to pregnancy
revisited: An update from the Danish
National Birth Cohort
Cathrine Carlsen Bach1*, Zeyan Liew2, Bodil Hammer Bech3, Ellen Aagaard Nohr4, Chunyuan Fei5,
Eva Cecilie Bonefeld-Jorgensen6, Tine Brink Henriksen1,7 and Jørn Olsen2,3Abstract
Background: We previously demonstrated an association between plasma perfluorooctane sulfonate (PFOS) and
perfluorooctanoate (PFOA) and longer time to pregnancy (TTP) in a sample from the Danish National Birth Cohort
(DNBC, 1996-2002). In this study we investigated this association in a new sample from the same cohort.
Methods: Sample 1 consisted of 440 women, and Sample 2 consisted of 1161 women from whom we previously
published the associations between PFOS or PFOA and TTP. We performed sample-specific and pooled analyses
using discrete-time survival analyses to estimate fecundability ratios according to PFOS and PFOA quartiles, adjusted
for potential confounders chosen guided by a directed acyclic graph. We also estimated odds ratios for infertility
(TTP > 12 months or infertility treatment) according to PFOS and PFOA by multivariable logistic regression.
Results: In Sample 1 PFOS was not associated with lower fecundability ratios or infertility, and there was a
tendency towards longer TTP with increasing PFOA only in parous women. In Sample 2 previously reported
associations were again seen. In the pooled analyses including both parous and nulliparous women fecundability
ratios were 13-22 % lower for the three higher quartiles of PFOS or PFOA compared to the reference quartile.
Conclusions: The pooled analyses were driven by the larger old sample, but we did not corroborate our previous
finding of an association between high PFOS and longer TTP in the new sample. The tendency towards an
association for PFOA and TTP in parous women may be due to reverse causation. Results from the new sample are
more in line with the recent literature.
Keywords: Female infertility, Fecundity, Reproduction, Perfluorooctane sulfonate, Perfluorooctanoate, Perfluorinated
chemicals, Epidemiology, HumansBackground
Fertility impairment is common and has severe conse-
quences for the affected individuals. Approximately 10 %
of all couples experience infertility lasting more than 12
months [1]. Several environmental and lifestyle factors in-
fluence human fertility, and perfluoroalkyl acids (PFAAs)
may be among these. PFAAs are a group of persistent en-
vironmental chemicals that have been used in a wide range
of products such as textiles including clothing and carpets,
footwear, non-stick pots and pans, and food packaging* Correspondence: ccbach@clin.au.dk
1Perinatal Epidemiology Research Unit, Aarhus University Hospital, Skejby,
Denmark
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creativecommons.org/publicdomain/zero/1.0/since the 1950s [2]. Even though the production of specific
PFAAs [perfluorooctane sulfonate (PFOS) and perfluorooc-
tanoate (PFOA)] has ceased in parts of the world [3–7],
they are resistant to degradation in the environment and
accumulate in the human organism [8]. Furthermore, these
compounds still occur in some imported products [9], and
they are being replaced by other compounds with similar
chemical structures.
A few studies have investigated the association be-
tween exposure to PFAAs and fecundability measured
by the time to pregnancy (TTP) in women [10–14]. TTP
is defined as the number of months, or menstrual cycles,
it takes for a sexually active couple to conceive from dis-
continuance of contraception. In our previous studycle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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found a strong association between exposure to PFOS or
PFOA and longer TTP [11]. Specifically, fecundability
odds ratios (FORs) were decreased by 30-40 % for the
three higher PFOS and PFOA quartiles compared to the
lowest. However, subsequent studies reported conflicting
results [10, 12–14]. Some studies found an association be-
tween PFAAs and TTP in parous, but not in nulliparous
women, and potential reverse causality in parous women
was discussed [12, 13, 15, 16]. In this study, we examined
if our previous findings on the associations between ex-
posure to PFOA and PFOS and TTP could be replicated
in an independent new sample of women from the
DNBC. We also reanalysed the data from our previous
study using a statistical strategy guided by directed acyclic
graphs (DAGs). In addition, we conducted pooled analyses
of the two samples providing the largest sample size to
date in population-based studies of the associations be-
tween PFAAs and TTP.
Methods
Setting
The DNBC is a nationwide cohort study that included
more than 100,000 pregnancies from 1996 to 2002; the de-
tails have been described previously [17]. Approximately
half of all general practitioners in Denmark took part and
recruited pregnant women during early pregnancy. About
60 % of the invited women participated. They donated
blood samples during the first and second trimesters and
provided information through structured telephoneFig 1 Flowchart of participants in two participant samples from the Danishinterviews twice during pregnancy and twice after birth.
The questionnaires used for the four interviews are avail-
able at www.dnbc.dk.
Participants
We studied two samples that were selected independently
from the DNBC during 1996-2002 (Fig. 1). The source
population for Sample 1 was women who gave birth to a
live born singleton, participated in the first telephone inter-
view, and provided a blood sample in the first or second
trimester (n = 83,389). From these we randomly se-
lected 550 participants who also served as controls in
a case-cohort study [18]. Women who gave birth to
boys were oversampled since the studied outcomes of
the case-cohort study have unequal sex ratios (off-
spring sex is unlikely to be related to the investigated
association).
Sample 2 (n = 1400) was randomly selected amongst par-
ticipants who provided the first blood sample during preg-
nancy, gave birth to a live born singleton without
congenital malformations, and completed the four sched-
uled interviews (n = 43,045). In this sample we previously
reported associations between PFOS and PFOA and time
to pregnancy [11].
We excluded 81 women from Sample 1 and 198 women
from Sample 2 since they did not plan their pregnancy, or
reported partly planning but did not provide a TTP. Partici-
pants with missing values for exposure, outcome (planned
pregnancy without a reported TTP), or covariates (3 % in
total) were further excluded from the main analysis. Finally,National Birth Cohort
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1161 participants in Sample 2 (Fig. 1).Exposure assessment
Blood samples from the women were collected by their
general practitioners during pregnancy and sent by mail
at ambient temperature to Statens Serum Institute. The
duration of transport was four to 48 h, but most sam-
ples arrived within 28 h. Upon arrival, samples were
stored in freezers at -20 °C, -80 °C, or in liquid nitrogen.
Plasma from Sample 1 was analysed in 2013 at the De-
partment of Environmental Science, Aarhus University,
Denmark. In Sample 2 we measured plasma concentra-
tions of PFOS and PFOA at the 3M Toxicology Labora-
tory in 2007 [11]. The details of the laboratory
procedures and equipment were described in a previous
paper [19]. Both laboratories were blinded to partici-
pant information and used similar analytical tech-
niques. PFAAs were abstracted from plasma by solid
phase extraction, and the concentrations of PFAAs
were assessed by liquid chromatography–tandem mass
spectrometry. For Sample 1, one blood sample was
missing and could therefore not be analysed for PFAA
content. For Sample 2, the analytic results for five sam-
ples were not usable and were thus excluded. Fifteen
samples overlapped between the two participant sam-
ples and were analysed in both laboratories for com-
parison. In the statistical analyses the women who
donated these samples were included in Sample 2. Mea-
sured concentrations in the duplicate samples were on
average 9.6 ng/mL lower for PFOS and 1.4 ng/mL lower
for PFOA at Aarhus University compared to the 3M la-
boratory [18]. Though the concentrations measured at
the two laboratories differed they were highly corre-
lated [Pearson correlation coefficient r = 0.94 for PFOS
and r = 0.95 for PFOA [18]]. All values were above the
limit of quantification (LOQ) in Sample 1, and for Sample
2, all values were above the LOQ, except one PFOA value
that was assigned half the LOQ.Outcomes
TTP was reported in the first interview performed at ap-
proximately 15 weeks of gestation. Women were asked
whether their pregnancy was planned, partly planned or
not planned. The women who answered “planned” or
“partly planned” were asked how long they tried to get
pregnant before they succeeded, and five response
categories were provided: pregnant immediately (<1
month), after 1-2, 3-5, 6-12, or after > 12 months. We
defined infertility as a TTP above 12 months or infertil-
ity treatment for the current pregnancy.Statistical analyses
Main analyses
Analyses on PFOA and PFOS and the TTP or infertility
were performed by each sample separately and as pooled
analyses combining the two samples. We performed all
analyses with and without stratification by parity (nul-
liparous versus parous women). Concentrations of PFOS
and PFOA were divided into quartiles, and we used the
lowest quartile as reference. To make the numbers in each
quartile evenly distributed, and to take different measure-
ments between the two laboratories into account, we gener-
ated quartiles for each participant sample, including parity-
specific quartiles for the parity-stratified analyses. In the 15
duplicate samples from the two laboratories women would
generally end up in the same quartile. All analyses were also
performed using natural log-transformed continuous ex-
posure concentrations.
To estimate fecundability ratios, we used a discrete-time
survival model with a complementary log-log link. The fe-
cundability ratio (FR) is the probability of conceiving in a
given interval in a group with higher exposure compared to
the reference group, conditionally on not having conceived
in the previous period. Thus, a FR below one indicates im-
paired fecundability as measured by a longer TTP. Women
who received infertility treatment were added to the highest
TTP category. We also performed multivariate logistic re-
gression analyses to estimate infertility odds ratios.
Selection of covariates was based on a DAG
(Additional file 1 Fig. 1) and included age (continuous),
pre-pregnancy body mass index (BMI, continuous),
socio-occupational status (higher versus middle/lower),
and parity (primiparous or multiparous). For the pooled
analyses of the two samples we additionally adjusted for
the sample (by use of a dummy variable assigning each
of the two samples with a different value) in order to ac-
count for differences in sampling and laboratories. The
data source for maternal age was the Danish Medical
Birth Registry, and for pre-pregnancy BMI and parity,
data was obtained from the first questionnaire in the
DNBC. Socio-occupational status was grouped based on
maternal education and job reported in the cohort or, if
this information was missing, the corresponding paternal
information. The statistical analyses were conducted
using STATA statistical software version 13 (StataCorp,
College Station, TX, USA).Sensitivity and bias analyses
Couples that had unplanned pregnancies, or pregnancies
with missing TTP for other reasons, may have either
high or low biological fecundity. We therefore per-
formed bias analyses that included these pregnancies
without a valid TTP in the lowest as well as in the high-
est TTP categories in order to examine the impact of
Bach et al. Environmental Health  (2015) 14:59 Page 4 of 8excluding women with missing TTP from our study
population.
We also restricted our analyses to women that pro-
vided a blood sample before 14 weeks of gestation since
maternal plasma concentrations of PFAAs decrease
during pregnancy, and therefore exposure assessment
may become less comparable with increasing pregnancy
duration. In order to take potential bias by the unequal
offspring sex ratio into account in Sample 1, we used in-
verse probability weighting. Whether to condition on
parity is a controversial issue, and in order to compare
our results with other studies, we also showed estimates
adjusted for age, BMI and socio-occupational status, but
not parity.
We did a posthoc analysis in Sample 1 restricted to
women who participated in all four interviews to assess
whether this restriction in Sample 2 could have caused
selection bias.
Ethical approval
The study was approved by the Danish Data protection
Agency (references 2012-41-1288 and 2006-41-6324),
and the Danish National Committee on Health Research
Ethics (reference M-20110054).Table 1 Participant characteristics for women from two samples of
Sample 1 (n = 440)
Percentage Median Int
PFOS (ng/mL) 27.9 21.
PFOA (ng/mL) 4.0 3.0
Age at delivery (years) 29 27
Parity 0 1+
48
52
Pre-pregnancy BMI (kg/m2) 22 21
SES Higher Middle/lower
50
50
Time to pregnancy (months) <1 1-2 3-5
26
24
22
15
13
Infertility 13
Abbreviations: Perfluorooctanoate (PFOA), perfluorooctane sulfonate (PFOS), Body M
Medians are listed for continuous variables and percentages for categorical variable
infertility treatment
SES definitions: Higher SES includes women with managerial posts and/or a job req
women who have a job requiring a shorter education, who do not have an educati
Missing values: One for age in Sample 2, none in Sample 1. None for parity in Samp
six values were missing for Sample 1. For SES, four values were missing for Sample
Sample 1 with planned pregnancies had missing time to pregnancy. One woman frResults
Characteristics of study participants are listed in Table 1.
Maternal age, parity, BMI, and socio-economic status as
well as the year of inclusion were comparable between
the two samples. A slightly higher proportion of women
had a TTP above 12 months or received infertility treat-
ment for the current pregnancy in Sample 2. Measured
average PFOS and PFOA levels were slightly lower for
Sample 1. Quartile limits for PFOS and PFOA are listed
by sample in Additional file 1 Table 1.
Perfluoroctane sulfonate and time to pregnancy and
infertility
In the pooled analysis for PFOS, fecundability was ap-
proximately 15 % lower in the three higher quartiles
compared to the reference (Table 2). In Sample 2, fe-
cundability ratios were slightly lower than for the pooled
sample, while in Sample 1, PFOS was not associated
with lower fecundability. After stratification by parity,
associations remained close to null in Sample 1. The es-
timates were slightly lower among nulliparous women,
but were attenuated in parous women from both Sample
2 and the pooled samples, compared with those ob-
served in all women (Table 3).the Danish National Birth Cohort
Sample 2 (n = 1161)
erquartile range Percentage Median Interquartile range
0 - 36.2 34.2 26.9 - 43.8
- 5.5 5.4 4.0 - 7.1
- 33 30 27 - 33
45
55
- 25 23 21 - 26
52
48
6-12 >12
23
25
20
16
16
17
ass Index (BMI), socio-economic status (SES)
s. Infertility was defined as a time to pregnancy >12 months or receiving
uiring a long or medium-cycle higher education. Middle/lower SES includes
on, or who do not have a job
le 2 and one in Sample 1. For BMI 33 values were missing for Sample 2, and
2, and two for Sample 1. Nine women from Sample 2 and three women from
om Sample 2 had missing data on both planner status and time to pregnancy
Table 2 Fecundability ratios according to plasma PFOS and PFOA
Sample 1 Sample 2 Pooled analysis
Crude FR Adjusteda FR 95 % CI Crude FR Adjusteda FR 95 % CI Crude FR Adjustedb FR 95 % CI
PFOS
Q1 1.00 1.00 1.00 1.00 1.00 1.00
Q2 1.06 1.08 0.81 - 1.44 0.79 0.79 0.66 - 0.95 0.85 0.87 0.75 - 1.02
Q3 0.99 0.99 0.73 - 1.34 0.80 0.78 0.65 - 0 .95 0.84 0.85 0.72 - 0.99
Q4 0.91 0.99 0.74 - 1.33 0.75 0.78 0.65 - 0.94 0.79 0.85 0.72 – 0.99
Log 0.94 0.96 0.75 – 1.24 0.74 0.76 0.62 – 0.92 0.79 0.83 0.72 – 0.97
PFOA
Q1 1.00 1.00 1.00 1.00 1.00 1.00
Q2 0.91 0.92 0.69 - 1.22 0.75 0.78 0.65 - 0.94 0.79 0.81 0.70 - 0.95
Q3 0.90 0.94 0.71 - 1.26 0.80 0.83 0.69 - 1.00 0.82 0.86 0.74 - 1.01
Q4 0.74 0.86 0.63 - 1.19 0.69 0.74 0.60 - 0.90 0.70 0.78 0.66 - 0.92
Log 0.75 0.89 0.68 – 1.15 0.69 0.72 0.61 – 0.85 0.70 0.77 0.67 – 0.89
aAdjusted for age, socio-economic status, body mass index, and parity. bAdditionally adjusted for sample
Abbreviations: Perfluorooctane sulfonate (PFOS), perfluorooctanoate (PFOA), quartile (Q), log-transformed continuous exposure levels (Log), fecundability ratio (FR),
95 % confidence interval (95 % CI)
The fecundability ratio denotes the probability of conceiving in a given interval in a group of women with higher exposure compared to the reference group,
conditionally on not having conceived in the previous period
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For PFOA, results from the pooled analyses were similar
to those for PFOS. The associations were stronger in
Sample 2 compared to Sample 1. Fecundability ratios
did not differ much between nulliparous and parous
women in the pooled sample and in Sample 2, but in
Sample 1 there was a tendency towards longer time to
pregnancy in parous, but not in nulliparous women
(Table 3). Infertility odds ratios were generally higher
with exposure to higher concentrations of PFOS or
PFOA in Sample 2 and the pooled sample, however the
confidence intervals were wider than for the fecundabil-
ity odds ratios. In Sample 1 the association was less clear
(Additional file 1 Tables 2 and 3).Sensitivity and bias analyses
When we included women with missing TTP in the lowest
TTP category, results remained unchanged, but when we
added them to the highest TTP category, no clear associa-
tions between exposure to PFOS or PFOA and the TTP
were evident (Additional file 1 Table 4). Restriction to par-
ticipants, who provided a blood sample before 14 weeks of
gestation [n = 403 (92 %) for Sample 1; n = 1147 (99 %) for
Sample 2], did not change our results. Neither did inverse
probability weighting for offspring sex in Sample 1. FRs
were slightly lower in analyses not adjusted for parity
(Additional file 1 Table 5).
In the posthoc analysis in Sample 1, restricted to
women, who participated in all four interviews, we
found estimates similar to the main analysis with wider
confidence intervals (Additional file 1 Table 6).Discussion
The reanalysis of data from our previous study as well as
the pooled analyses indicated as before an association
between exposure to PFOS or PFOA and TTP, inde-
pendent of parity. However, results from the new Sample
1 did not support an association between PFOS and
TTP while for PFOA, there was a tendency towards an
association with TTP in parous women, but not in nul-
liparous women.
Sample 1 was smaller than Sample 2 and therefore
more prone to random fluctuations as illustrated by the
wider confidence intervals, but the results from this
sample were more similar to results from most previous
studies [10, 12–14]. Differences between the two sam-
ples may be due to random forces or systematic differ-
ences, for instance due to differences in sampling or use
of different laboratories. It is notable that women in the
lowest PFAA quartile in Sample 2 had very short TTP,
and no clear dose-response pattern was seen in the
main quartile analyses. Such a pattern was present in
Sample 2 among nulliparous women upon stratification.
Results from our reanalysis of Sample 2 were consistent
with results from our previous study [11] as expected, even
though we used different statistical approaches, including a
different set of covariates. Two smaller pregnancy planner
studies, Vestergaard et al. (2012) from Denmark and Buck
Louis et al. (2013) from the USA, followed couples that
attempted to conceive for six and 12 months, respectively.
They found no associations between exposure to PFOS or
PFOA and fecundability odds ratios or infertility with point
estimates very close to 1. Vestergaard et al. (2012) only in-
cluded nulliparous women while Buck Louis et al. (2013)
Table 3 Fecundability ratios according to plasma PFOS and PFOA by parity
Sample 1 Sample 2 Pooled analysis
Crude FR Adjusteda FR 95 % CI Crude FR Adjusteda FR 95 % CI Crude FR Adjustedb FR 95 % CI
PFOS
N Q1 1.00 1.00 1.00 1.00 1.00 1.00
Q2 1.16 1.16 0.77 - 1.75 0.97 0.89 0.68 - 1.17 1.02 0.98 0.78 - 1.23
Q3 1.07 1.01 0.65 - 1.57 0.80 0.68 0.52 - 0.91 0.87 0.78 0.62 – 1.00
Q4 0.98 0.97 0.62 - 1.51 0.79 0.69 0.53 - 0.91 0.84 0.79 0.63 – 0.99
Log 1.06 1.02 0.72 – 1.44 0.75 0.62 0.47 – 0.83 0.86 0.78 0.63 – 0.97
P Q1 1.00 1.00 1.00 1.00 1.00 1.00
Q2 0.91 1.04 0.69 - 1.55 0.86 0.88 0.69 - 1.12 0.88 0.92 0.75 - 1.14
Q3 0.95 1.05 0.69 - 1.60 0.71 0.72 0.56 – 0.94 0.77 0.80 0.65 – 0.99
Q4 0.89 1.04 0.70 - 1.55 0.84 0.90 0.70 - 1.14 0.85 0.93 0.76 - 1.15
Log 0.82 0.91 0.63 – 1.30 0.79 0.85 0.66 – 1.09 0.77 0.86 0.70 – 1.06
PFOA
N Q1 1.00 1.00 1.00 1.00 1.00 1.00
Q2 0.88 0.82 0.53 – 1.26 1.09 0.93 0.71 - 1.23 1.03 0.90 0.71 - 1.13
Q3 1.15 1.11 0.73 – 1.69 0.94 0.80 0.71 - 1.07 0.99 0.90 0.71 - 1.13
Q4 0.98 0.99 0.64 – 1.54 0.82 0.74 0.56 - 0.98 0.86 0.82 0.65 - 1.04
Log 1.23 1.26 0.86 – 1.85 0.73 0.67 0.51 – 0.88 0.87 0.84 0.67 – 1.05
P Q1 1.00 1.00 1.00 1.00 1.00 1.00
Q2 1.19 1.30 0.86 – 1.98 0.78 0.76 0.59 - 0.96 0.85 0.86 0.70 – 1.06
Q3 0.93 0.96 0.66 - 1.41 0.69 0.71 0.56 – 0.90 0.74 0.78 0.63 - 0.94
Q4 0.70 0.74 0.48 - 1.13 0.76 0.78 0.61 – 0.99 0.74 0.76 0.61 – 0.94
Log 0.64 0.66 0.46 – 0.95 0.74 0.76 0.61 – 0.93 0.68 0.72 0.61 – 0.87
aAdjusted for age, socio-economic status, and body mass index. bAdditionally adjusted for sample
Abbreviations: Perfluorooctane sulfonate (PFOS), perfluorooctanoate (PFOA), nulliparous women (N), parous women (P), quartile (Q), log-transformed continuous
exposure levels (Log), fecundability ratio (FR), 95 % confidence interval (95 % CI)
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studied women from Greenland, Poland, and Ukraine and
found no association between PFOA and fecundability or
infertility. In their analyses including both nulliparous and
parous women there was a tendency towards lower fecund-
ability and infertility with increasing PFOS, but this ten-
dency disappeared when they restricted to nulliparous
women. A Norwegian case-control study by Whitworth
et al. (2012) found increased odds for infertility with expos-
ure to PFOS or PFOA only in parous women, which they
suggested could reflect reverse causality [13]. During preg-
nancy, delivery and lactation, PFAA concentrations de-
crease in maternal blood [20]. After this period,
concentrations may slowly increase again, and a longer
interval between the birth of one child and a subsequent
pregnancy may therefore correlate with higher PFAA con-
centrations [12, 13, 21], which may induce a spurious asso-
ciation between PFAA concentrations and TTP in parous
women. Only our results for Sample 1 regarding PFOA
supported this explanation, but parity remains an important
factor to control since it is likely to be associated with bothindividual PFAA levels and the TTP (through determinants
of individual fecundability, see Additional file 1 Fig. 1).
Blood samples from our two DNBC samples were ana-
lysed in two different laboratories, and although paired
measurements from the two laboratories were highly
correlated, differing measurement errors may play a role.
We addressed potential differences between the two la-
boratories by categorizing exposure before pooling the
two samples and adjusting for the sample.
The causal window of interest may be when a couple
initiates their attempt to conceive [10, 12]. We measured
exposure in the first or second trimester, and levels at
that time probably correlated closely with those at initi-
ation of the attempt to conceive. Although PFAA con-
centrations decrease during gestation [20, 21], gestational
age at blood drawing is not likely to be associated with
TTP. Analyses with restriction to samples taken before
gestational week 14 produced similar results. Samples
were transported for one to two days at ambient
temperature and stored for several years before analyses,
and in spite of the environmental persistency and long
Bach et al. Environmental Health  (2015) 14:59 Page 7 of 8half-lives of PFAAs [22] this may be a problem. However, it
is unlikely that any measurement error due to ex vivo deg-
radation is associated with TTP, but random measurement
error may bias results, most likely towards the null. We did
not measure the glomerular filtration rate, which may affect
both PFAA levels and the fecundability.
TTP is a measure of couple fecundability. Exposures
in men could potentially affect male fertility.
We did not measure PFAA levels in the partners of
our participants, but the association between exposures
in women and TTP might potentially reflect a causal as-
sociation between male exposure and fertility. Exposures
in couples are expected to be correlated due to similar
lifestyle and home environment. The association be-
tween PFAA exposure and male reproductive function
has been investigated in several studies, but few studies
demonstrated any convincing associations [10, 23–30].
We had no information on other determinants of TTP
including family planning patterns such as discontinu-
ance of birth control, frequency and timing of inter-
course, and persistency in the attempt to become
pregnant. However, we do not believe that these factors
are directly associated with PFAA levels.
All women in the study gave birth to a live born child.
Couples with unresolved infertility, spontaneous abortions,
or stillbirths are therefore not studied. We were unable to
include women with missing TTP, who were most likely to
have conceived unexpectedly, but we found that their con-
centrations of both PFOA and PFOS were approximately
10 % lower compared to those included. Exclusion of this
particular group could underestimate the association if
their TTP was short, and vice versa if it was long. However,
inclusion of these women in the lowest TTP category did
not strengthen the associations (Additional file 1 Table 4).
Adding them to the highest TTP category removed the ob-
served associations, which may be explained by the lower
PFAA concentrations in these women. Recall of TTP
during pregnancy may be imperfect, but the recall time
period was short, and differential misclassification concern-
ing TTP is unlikely since participants were unaware of
exposure concentrations.
Bias due to the women’s willingness to participate in
the cohort is unlikely since women were unaware of
their PFAA levels, even though it is possible that selec-
tion depended on other factors associated with both
PFAA concentrations and the TTP. The main difference
between the source populations for the two samples was
that Sample 1 was sampled from women, who com-
pleted the first interview independently of their completion
of the following three interviews, and Sample 2 was sam-
pled from women that completed all four interviews.
Therefore, the source population for Sample 2 was approxi-
mately half the size of the source population for Sample 1
(Fig. 1). However, baseline characteristics and TTPdistributions were similar for women in the two DNBC
source populations, who participated in all four interviews
(n = 43,045) or the first interview independently of partici-
pation in the three latter (n = 83,389). Both samples seem
to be representative for their source populations, even
though we observed slightly shorter average TTP in Sample
1 compared with Sample 2. Estimates from Sample 1 re-
stricted to women, who participated in all four interviews,
were similar to the main analysis, and therefore we assume
that any selection bias in either sample is unlikely to be due
to the different sampling strategies.
Conclusions
We did not corroborate our previous finding of an associ-
ation between higher PFOS and longer TTP using a new
participant sample from the DNBC. Regarding PFOA, we
identified an association with TTP only in parous women
in this sample. Overall, pooled analyses of the two samples
still indicated that high levels of maternal PFOA and PFOS
were associated with longer TTP, regardless of parity, but
these results were primarily driven by the larger sample
from our previous study. Results from the new Sample 1
add uncertainty to the results from our older Sample 2, es-
pecially for PFOS. We found no dose-response pattern in
Sample 2 in which the associations were mainly based upon
short TTP in the low exposure group. Results from the
new sample are more in line with the rest of the existing
literature, and therefore convincing evidence for an associ-
ation between exposure to PFOA or PFOS and TTP is still
lacking.
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